| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 98.9 | 87.6 | +12.8% |
| EBITDA | 3.3 | 14.9 | −77.7% |
| EBITDA margin | 3.3% | 17.0% | −13.6 pts |
| Profit before tax | −8.5 | 10.8 | — |
| Net profit | −7.9 | 8.0 | — |
| EPS | −₹1.56 | ₹1.70 | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 |
|---|
| 729 | — | |
| 8.1 | 8.1 | |
| 150 | 150 | |
| 870 | — | |
| 378 | 366 | |
| 29.1 | 40.8 | |
| 7.7% | 11.1% | |
| −0.8 | 18.2 | |
| −14.4 | 1.4 | |
| −3.8% | 0.4% | |
| −₹2.76 | ₹0.27 | |
| — | 29.6 | |
| — | −95.1 | |
| −65.5 | −65.5 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|
| Market Capitalization | — | 728.8 | |
| - Cash, Equiv & ST Investments | 8.1 | 8.1 | |
| + Total Debt | 149.8 | 149.8 | |
| Enterprise Value | — | 870.5 | |
| Revenue | 366.5 | 377.7 | |
| EBITDA | 40.8 | 29.1 | |
| Margin % | 11.12 | 7.70 | |
| EBIT | 18.2 | -0.8 | |
| Net Income | 1.4 | -14.4 | |
| Margin % | 0.39 | -3.82 | |
| EPS, Adj (current shares) | 0.27 | -2.76 | |
| Cash from Operations | 29.6 | — | |
| Capital Expenditures | -95.1 | — | |
| Free Cash Flow | -65.5 | -65.5 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Gem Aromatics (NSE: GEMAROMA) had a market capitalisation of ₹716 crore at the 30 October 2026 close (₹137.04 a share) and a price-to-book ratio of 1.59. In FY26 its consolidated net profit was ₹1.4 crore on revenue of ₹366 crore; in Q1 FY27 (April–June 2026) it was a loss of ₹7.9 crore. Its debt-to-equity ratio was 0.33 on 31 March 2026. Promoters held 57.45% of the shares on 30 September 2026.
Gem Aromatics' PE ratio is not meaningful at the 30 October 2026 close: its consolidated net profit over the last four quarters (Q2 FY26 to Q1 FY27) was a loss of ₹14.4 crore, and a price-to-earnings ratio needs positive earnings. Its market capitalisation was ₹716 crore at ₹137.04 a share.
Gem Aromatics' price-to-book (PB) ratio is 1.59 at the 30 October 2026 close: a market capitalisation of ₹716 crore divided by shareholders' equity (book value) of ₹450 crore on 31 March 2026. That is a book value of ₹86.14 per share against a share price of ₹137.04.
Gem Aromatics' net worth — shareholders' equity in its consolidated balance sheet — was ₹450 crore on 31 March 2026. Its market value is a different figure: a market capitalisation of ₹716 crore at the 30 October 2026 close.
Gem Aromatics' market capitalisation was ₹716 crore at the 30 October 2026 close: 5.22 crore shares at ₹137.04 each.
No. Gem Aromatics had borrowings of ₹150 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.33. Its cash and current investments were ₹15.9 crore, so its net debt was ₹134 crore.
Gem Aromatics' debt-to-equity ratio was 0.33 on 31 March 2026: borrowings of ₹150 crore against total equity of ₹450 crore.
Gem Aromatics' book value per share was ₹86.14 on 31 March 2026: shareholders' equity of ₹450 crore divided by the 5.22 crore shares in issue. The share price at the 30 October 2026 close was ₹137.04.
Promoters held 57.45% of Gem Aromatics on 30 September 2026, unchanged from the previous quarter and up 2.39 percentage points from 55.06% a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Gem Aromatics generated ₹29.6 crore of cash from operations and spent ₹95.1 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹65.5 crore.
Gem Aromatics' basic earnings per share (EPS) were ₹0.28 in FY26.
In FY26 (April 2025–March 2026), Gem Aromatics' consolidated net profit was ₹1.4 crore, on revenue from operations of ₹366 crore.
Gem Aromatics will announce its Q2 FY27 results (July–September 2026) on Saturday, 31 October 2026, the date of the board meeting it has notified to the exchanges.
On 30 September 2026, Gem Aromatics' shares were held by promoters 57.45%, foreign portfolio investors (FII/FPI) 0.39%, domestic institutions (DII) 4.95% and retail and other non-institutional investors 37.21%. Over the year, FII holding was down 1.62 percentage points from 2.01% and DII holding was down 1.61 percentage points from 6.56%.
At the 30 October 2026 closing prices, on FY26 net profit, Gem Aromatics' PE ratio is 502.3, the highest of the four: Sudarshan Colorants India 19.2, Sree Rayalaseema Hi-Strength Hypo 9.2 and Amines & Plasticizers 21.4, a peer average of 16.6. Each is the company's market capitalisation at that price divided by its FY26 net profit.
In FY26, Gem Aromatics earned net profit of ₹1.4 crore on revenue of ₹366 crore, against ₹44.5 crore on ₹781 crore for Sudarshan Colorants India. Gem Aromatics' operating margin was 5.0% (Sudarshan Colorants India 4.9%). At the 30 October 2026 close, Gem Aromatics' market capitalisation was ₹716 crore against ₹856 crore for Sudarshan Colorants India, and its PE ratio on FY26 profit 502.3 against 19.2.
Gem Aromatics' latest results are for Q1 FY27 (April–June 2026), filed on 13 August 2026: consolidated net loss ₹7.9 crore, against a profit of ₹8 crore in Q1 FY26; revenue from operations ₹98.9 crore, up 12.8% year on year.
On FY26 consolidated figures, against Sudarshan Colorants India, Sree Rayalaseema Hi-Strength Hypo and Amines & Plasticizers: Gem Aromatics' operating margin of 5.0% is the third highest of the four (Sudarshan Colorants India 4.9%, Sree Rayalaseema Hi-Strength Hypo 12.2%, Amines & Plasticizers 9.5%; peer average 8.9%).
From Gem Aromatics' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.